Hemosol B0

Hemosol B0 is a sterile electrolyte solution for injection that contains calcium, lactic acid, magnesium, sodium, chloride ion, and hydrogen carbonate. It is supplied as a ready‑to‑use liquid for intravenous administration during hemodialysis. The formulation provides essential electrolytes and buffering capacity to support acid‑base balance in patients undergoing renal replacement therapy. It is marketed in the European Union and conforms to EU pharmacopeial standards for purity and sterility.

Hemosol B0 is indicated for use as the dialysate solution in hemodialysis and other renal replacement therapies. It supplies the electrolytes and buffering agents required to maintain physiological homeostasis during treatment.

- Provides calcium, magnesium, sodium, chloride, and bicarbonate during dialysis. - Helps regulate acid‑base balance through lactic acid buffering. - Supports cardiovascular stability by maintaining electrolyte concentrations. - Compatible with standard hemodialysis machines and circuits. - Used in continuous renal replacement therapy (CRRT) where precise electrolyte control is needed.

Adverse reactions to Hemosol B0 are generally related to its electrolyte composition and are reported infrequently.

Common: - Mild nausea or vomiting. - Transient hypotension during dialysis. - Mild pruritus at the infusion site.

Serious: - Severe hypercalcemia or hypermagnesemia. - Metabolic alkalosis. - Cardiac arrhythmias related to electrolyte imbalance. - Anaphylactic reactions to solution components.

When using Hemosol B0, clinicians should assess patient-specific factors and monitor laboratory values to minimize risks.

- Verify baseline serum calcium, magnesium, and bicarbonate levels before initiation. - Adjust dialysate composition for patients with known electrolyte disorders. - Use caution in patients with cardiac disease or arrhythmias. - Monitor blood pressure and heart rate throughout the session. - Observe for signs of fluid overload or electrolyte shifts. - Avoid use in patients with known hypersensitivity to any component. - Ensure proper storage at recommended temperature to maintain solution stability.

Hemosol B0 may interact with medications that affect electrolyte balance or acid‑base status.

Avoid: - Calcium channel blockers that could exacerbate hypercalcemia. - Magnesium‑containing laxatives or antacids when high magnesium levels are present. - Sodium bicarbonate infusions that may cause excessive alkalinity.

Use with caution: - Loop diuretics that alter sodium and calcium excretion. - ACE inhibitors or ARBs in patients prone to hyperkalemia. - Vitamin D analogues that increase calcium absorption. - Blood transfusions that may affect serum calcium concentrations.